|
Sanchez-Mas J, Lax A, Asensio-Lopez MC, Fernandez-Del Palacio MJ, Caballero L, Garrido IP, Pastor F, Januzzi JL, Pascual-Figal DA. Galectin-3 expression in cardiac remodeling after myocardial infarction. Int J Cardiol. 2014;172(1):e98-e101. doi: 10.1016/j.ijcard.2013.12.129. PubMed PMID: 24433619.
AÑO: 2014; IF: 4.036
|
24433619
|
Flores-Blanco PJ, Manzano-Fernández S, Pérez-Calvo JI, Pastor-Pérez FJ, Ruiz-Ruiz FJ, Carrasco-Sánchez FJ, Morales-Rull JL, Pascual-Figal D, Galisteo-Almeda L, Januzzi JL. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure. Clin Cardiol. 2015 Feb;38(2):106-13. doi: 10.1002/clc.22362. PubMed PMID: 25663560.
AÑO: 2015; IF: 2.431
|
|
Lax A, Sanchez-Mas J, Asensio-Lopez MC, Fernandez-Del Palacio MJ, Caballero L, Garrido IP, Pastor-Perez FJ, Januzzi JL, Pascual-Figal DA. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction. JACC Heart Fail. 2015 Jan;3(1):50-8. doi: 10.1016/j.jchf.2014.07.015. PubMed PMID: 25458175.
AÑO: 2015; IF: 7.218
|
|
Delgado JF, Oliva J, Llano M, Pascual-Figal D, Grillo JJ, Comín-Colet J, Díaz B, Martínez de La Concha L, Martí B, Peña LM. Health care and nonhealth care costs in the treatment of patients with symptomatic chronic heart failure in Spain. Rev Esp Cardiol (Engl Ed). 2014 Aug;67(8):643-50. doi: 10.1016/j.rec.2013.12.014. PubMed PMID: 25037543.
AÑO: 2014; IF: 3.792
|
|
Sánchez-Más J, Lax A, Asensio-López Mdel C, Fernandez-Del Palacio MJ, Caballero L, Santarelli G, Januzzi JL, Pascual-Figal DA. Modulation of IL-33/ST2 system in postinfarction heart failure: correlation with cardiac remodelling markers. Eur J Clin Invest. 2014 Jul;44(7):643-51. doi: 10.1111/eci.12282. PubMed PMID: 24837094.
AÑO: 2014; IF: 2.734
|